Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
aldeheby应助闷声发采纳,获得10
2秒前
ljy1111发布了新的文献求助10
2秒前
2秒前
2秒前
泅渡完成签到,获得积分20
3秒前
vigor完成签到 ,获得积分10
3秒前
3秒前
4秒前
逗逗发布了新的文献求助10
4秒前
orixero应助Iris采纳,获得10
4秒前
4秒前
鹅鹅完成签到 ,获得积分10
4秒前
hard完成签到,获得积分10
5秒前
CocoGabrielle完成签到,获得积分10
5秒前
5秒前
的奖学金喜欢喜欢大呼小叫难受完成签到 ,获得积分10
6秒前
ABC的FGH发布了新的文献求助10
6秒前
6秒前
思源应助韩妙采纳,获得10
6秒前
研友_8yN60L完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
子晏发布了新的文献求助10
8秒前
wuyoucaoxin完成签到,获得积分10
9秒前
直率初露发布了新的文献求助10
9秒前
yc发布了新的文献求助10
10秒前
科研通AI2S应助lidd采纳,获得10
10秒前
fff完成签到,获得积分10
10秒前
平淡惋清发布了新的文献求助10
11秒前
11秒前
11秒前
小窝发布了新的文献求助10
11秒前
Akim应助itharmony采纳,获得10
12秒前
czt完成签到,获得积分10
12秒前
ZHa0发布了新的文献求助10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
《药学类医疗服务价格项目立项指南(征求意见稿)》 880
Stop Talking About Wellbeing: A Pragmatic Approach to Teacher Workload 800
花の香りの秘密―遺伝子情報から機能性まで 800
3rd Edition Group Dynamics in Exercise and Sport Psychology New Perspectives Edited By Mark R. Beauchamp, Mark Eys Copyright 2025 600
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Terminologia Embryologica 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5618526
求助须知:如何正确求助?哪些是违规求助? 4703500
关于积分的说明 14922583
捐赠科研通 4757805
什么是DOI,文献DOI怎么找? 2550140
邀请新用户注册赠送积分活动 1512973
关于科研通互助平台的介绍 1474342